1 / 21

Big Pharma , Little Science? A bibliometric perspective on big pharma’s R&D decline

Big Pharma , Little Science? A bibliometric perspective on big pharma’s R&D decline. Ismael Rafols 1,2,* , Michael M. Hopkins 1 , Jarno Hoekman 3 , Josh Siepel 1 , Alice O'Hare 1 , Antonio Perianes-Rodríguez 4 and Paul Nightingale 1

aislin
Télécharger la présentation

Big Pharma , Little Science? A bibliometric perspective on big pharma’s R&D decline

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Big Pharma, Little Science?A bibliometric perspective on big pharma’s R&D decline Ismael Rafols1,2,*, Michael M. Hopkins1, Jarno Hoekman3, Josh Siepel1, Alice O'Hare1, Antonio Perianes-Rodríguez4 and Paul Nightingale1 1 SPRU – Science and Technology Policy Research, University of Sussex, Brighton, England 2 INGENIO (CSIC-UPV), UniversitatPolitècnica de València, València, Spain 3 Eindhoven Centre for Innovation Studies (ECIS), Eindhoven University of Technology, Eindhoven, The Netherlands 4Carlos III University of Madrid, Department of Library and Information Science, SCImago Research Group, Madrid, Spain

  2. Pharma Specialisation (Aggregate)

  3. Specialisation by firm

More Related